Type 2 Diabetes

SEP 11, 2026 · INTERVENTIONAL STUDY

MagDI Australia Study

ClinicalTrials.gov

Registry record of a completed single-arm feasibility study in a small population (n=25) evaluating a novel device; no results are posted, and the primary focus is procedural feasibility and safety rather than clinical efficacy.

SEP 10, 2026 · PHASE 1/2 TRIAL

A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D

ClinicalTrials.gov

This is a first-in-human Phase 1/2 trial registration with no results reported; the record describes planned enrollment and safety endpoints only.

SEP 9, 2026 · PHASE 2 TRIAL

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

ClinicalTrials.gov

Phase 2 trial with completed enrollment but no results posted; design and primary outcome are specified but efficacy and safety data are not yet reported in this registry record.

SEP 9, 2026 · OBSERVATIONAL STUDY

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

ClinicalTrials.gov

This is a clinical trial registry record describing a planned observational study with no results posted; it documents study design and intended outcomes only, not evidence of efficacy or safety.

AUG 7, 2026 · INTERVENTIONAL STUDY

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

ClinicalTrials.gov

This is a completed interventional trial in adolescents with type 2 diabetes testing time-limited eating; no results are posted in this registry record, making it preliminary evidence with outcomes yet to be reported.

AUG 6, 2026 · OBSERVATIONAL STUDY

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

ClinicalTrials.gov

Registry record for an observational study with completed enrollment; no results posted, so evidence quality cannot be assessed.

AUG 3, 2026 · PHASE 3 TRIAL

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

ClinicalTrials.gov

This is an active Phase 3 RCT registration with no posted results; the study design and planned enrollment are reported but outcomes remain unknown.

JUL 24, 2026 · JOURNAL ARTICLE

The dietary pattern derived by reduced-rank regression in association with novel atherogenic risk factors in patients with type 2 diabetes: a cross-sectional study.

Journal of Diabetes and Metabolic Disorders

Cross-sectional association study showing reduced odds of atherogenic indices with healthy dietary pattern in T2DM, but causality cannot be established and prospective validation is needed.